Abstract

BackgroundFUS (TLS) and EWS (EWSR1) belong to the FET-protein family of RNA and DNA binding proteins. FUS and EWS are structurally and functionally related and participate in transcriptional regulation and RNA processing. FUS and EWS are identified in translocation generated cancer fusion proteins and involved in the human neurological diseases amyotrophic lateral sclerosis and fronto-temporal lobar degeneration.ResultsTo determine the gene regulatory functions of FUS and EWS at the level of chromatin, we have performed chromatin immunoprecipitation followed by next generation sequencing (ChIP-seq). Our results show that FUS and EWS bind to a subset of actively transcribed genes, that binding often is downstream the poly(A)-signal, and that binding overlaps with RNA polymerase II. Functional examinations of selected target genes identified that FUS and EWS can regulate gene expression at different levels. Gene Ontology analyses showed that FUS and EWS target genes preferentially encode proteins involved in regulatory processes at the RNA level.ConclusionsThe presented results yield new insights into gene interactions of EWS and FUS and have identified a set of FUS and EWS target genes involved in pathways at the RNA regulatory level with potential to mediate normal and disease-associated functions of the FUS and EWS proteins.Electronic supplementary materialThe online version of this article (doi:10.1186/s12864-015-2125-9) contains supplementary material, which is available to authorized users.

Highlights

  • FUS (TLS) and EWS (EWSR1) belong to the FET-protein family of RNA and DNA binding proteins

  • FET-proteins are involved in neurological diseases with FUS and TAF15 mutations identified in familial amyotrophic lateral sclerosis (ALS) [5,6,7,8], frontotemporal

  • In this study we have performed chromatin immunoprecipitation followed by generation sequencing (ChIP-seq) to identify potential binding sites of FUS and EWS at the chromatin level

Read more

Summary

Introduction

FUS (TLS) and EWS (EWSR1) belong to the FET-protein family of RNA and DNA binding proteins. FUS and EWS are identified in translocation generated cancer fusion proteins and involved in the human neurological diseases amyotrophic lateral sclerosis and fronto-temporal lobar degeneration. The FET-protein family comprises FUS (fused in sarcoma, and abbreviated TLS (translocated in liposarcoma)), EWS (Ewing sarcoma breakpoint region 1, and abbreviated EWSR1) and TAF15 (TATA box binding protein associated factor 68 kDa) [1]. FET-proteins are involved in neurological diseases with FUS and TAF15 mutations identified in familial amyotrophic lateral sclerosis (ALS) [5,6,7,8], frontotemporal. The N-terminal region of FET-proteins has a transcriptional transactivating function and is involved in homo and hetero dimerization [2, 13]. As well as FUS and TAF15 mutations present in ALS and FTLD, results in cytoplasmic aggregation, appearing as immune reactive inclusion

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call